Use of isotope ratio mass spectrometry to detect doping with oral testosterone undecanoate: Inter-individual variability of 13C/12C ratio

Steroids

Volumn 71, Issue 5, 2006, Pages 364-370

  Baume, Norbert ^a   Saudan, Christophe ^a   Desmarchelier, Aurélien ^a   Strahm, Emmanuel ^a   Sottas, Pierre Edouard ^a   Bagutti, Carlo ^b   Cauderay, Michel ^c   Schumacher, Yorck Olaf ^d   Mangin, Patrice ^a   Saugy, Martial ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b Ctr Medico chirurgical de Vidy   (Switzerland)

^c Hopital Riviera   (Switzerland)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Doping control; Isotope ratio mass spectrometry (IRMS); Multiple administrations; Testosterone undecanoate (TU)

Indexed keywords

ANDROSTANE DERIVATIVE; ANDROSTERONE; CARBON; CARBON 13; DRUG METABOLITE; ETIOCHOLANOLONE; ISOTOPE; TESTOSTERONE UNDECANOATE;

ADULT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DOPING; DRUG ACCUMULATION; DRUG DOSE REGIMEN; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; ISOTOPE ANALYSIS; ISOTOPE LABELING; KIDNEY CLEARANCE; MALE; MASS SPECTROMETRY; METABOLISM; NORMAL HUMAN; STATISTICAL SIGNIFICANCE; URINALYSIS; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; CARBON ISOTOPES; DOPING IN SPORTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; REFERENCE VALUES; SUBSTANCE ABUSE DETECTION; TESTOSTERONE; TIME FACTORS; VARIATION (GENETICS);

EID: 33646468993     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2005.11.004     Document Type: Article

References (22)

1. Perry P.J., MacIndoe J.H., Yates W.R., Scott S.D., and Holman T.L. Detection of anabolic steroid administration: ratio of urinary testosterone to epitestosterone vs the ratio of urinary testosterone to luteinizing hormone. Clin Chem 43 (1997) 731-735
2. Carlström K., Palonek E., Garle M., Oftebro H., Stanghelle J., and Björkhem I. Detection of testosterone administration by increased ratio between serum concentrations of testosterone and 17α-hydroxyprogesterone. Clin Chem 38 (1992) 1779-1784
3. WADA technical document: reporting and evaluation guidance for testosterone, epitestosterone, T/E ratio and other endogenous steroids; 2004. http://www.wada-ama.org.
4. Davidson D.W., O'Carroll R., and Bancroft J. Increasing circulating androgens with oral testosterone undecanoate in eugonadal men. J Steroids Biochem Mol Biol 26 (1987) 713-715
5. Giagulli V.A., Verdonck L., Deslypere J.P., Giorgino R., and Vermeulen A. Comparison of plasma androgen glucuronide levels after percutaneous or peroral androgen treatment in men: evidence for important splanchnic contribution to plasma 17β-hydroxyandrogen glucuronides. J Clin Endocrinol Metab 76 (1993) 429-431
6. Nieschlag E., Mauss J., Coert A., and Kićovic P. Plasma androgen levels in men after oral administration of testosterone or testosterone undecaonate. Acta Endocrinol 79 (1975) 366-374
7. Coert A., Geelen J., de Visser J., and van der Vies J. The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen. Acta Endocrinol 79 (1975) 789-800
8. Wright F., Lafarge J.P., Antréassian J., Lagoguey M., and Pérès G. Long term study of steroid and peptidic hormones in the plasma of healthy young men under controlled testosterone undecanoate therapy. In: Hemmersbach P., and Birkeland K.I. (Eds). Blood samples for doping control (1994), Oslo, Pensumtjeneste 65-74
9. Maître A., Saudan C., Mangin P., and Saugy M. Urinary analysis of four testosterone metabolites and pregnanediol by gas chromatography/combustion/isotope ratio mass spectrometry after oral administrations of testosterone. J Anal Toxicol 28 (2004) 426-431
10. Peng S.H., Segura J., Farré M., González J.C., and de la Torre X. Plasma and urinary markers of oral testosterone undecanoate misuse. Steroids 67 (2002) 39-50
11. Palonek E., Gottlieb C., Garle M., Björkhem I., and Carlström K. Serum and urinary markers of exogenous testosterone administration. J Steroids Biochem Mol Biol 55 (1995) 121-127
12. Dehennin L., and Matsumoto A.M. Long-term administration of testosterone enanthate to normal men: alterations of the urinary profile of androgen metabolites potentially useful for detection of testosterone misuse in sport. J Steroids Biochem Mol Biol 44 (1993) 179-189
13. Saudan C., Baume N., Mangin P., and Saugy M. Urinary analysis of 16(5α)-androsten-3α-ol by gas chromatography/combustion/isotope ratio mass spectrometry: implications in anti-doping analysis. J Chromatogr B 810 (2004) 157-164
14. Dehennin L., and Peres G. Plasma and urinary markers of oral testosterone misuse by healthy men in presence of masking epitestosterone administration. Int J Sports Med 17 (1996) 315-319
15. Coffman B.L., King C.D., Rios G.R., and Tephly T.R. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Disp 26 (1998) 73-77
16. de Wildt S.N., Kearns G.L., Leeder J.S., and van der Anker J.N. Glucuronidation in humans: pharmacogenetic and developmental aspect. Clin Pharmacokinet 36 (1999) 439-452
17. Shackleton CHL, Phillips A., Chang T., and Li Y. Confirming testosterone administration by isotope ratio mass spectrometric analysis of urinary androstanediols. Steroids 62 (1997) 379-387
18. 12C isotope ratio of the hormones in bovine urine using gas chromatography/combustion/isotope ratio mass spectrometry. J Chromatogr A 1067 (2005) 323-330
19. Aguilera R., Chapman T.E., Starcevic B., Hatton C.K., and Catlin D.H. Performance characteristics of a carbon isotope ratio method for detecting doping with testosterone based on urine diols: controls and athletes with elevated testosterone/epitestosterone ratios. Clin Chem 47 (2001) 292-300
20. 12C isotope ratio MS analysis of testosterone, in chemicals and pharmaceutical preparations. J Pharm Biomed Anal 24 (2001) 645-650
21. Brenna J.T. Natural intramolecular isotope measurements in physiology: elements of the case for an effort toward high-precision position-specific isotope analysis. Rapid Commun Spectrom 15 (2001) 1252-1262
22. Shackleton CHL, Chuang H., Kim J., de la Torre X., and Segura J. Electrospray mass spectrometry of testosterone esters: potential for use in doping control. Steroids 62 (1997) 523-529